Improving cervical cancer treatment options for women in low and middle-income countries
Optimizing ablation of cervical precancer with ethyl cellulose ethanol to enable translation to women in low and middle-income countries
This study is working on creating affordable and easy-to-use treatments for cervical precancer, especially for women in low and middle-income countries, so they can get the care they need without complicated equipment.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Calla Health Foundation NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10932427 on NIH RePORTER |
What this research studies
This research focuses on developing low-cost and effective treatments for cervical precancer using ethyl cellulose ethanol. It aims to create simple-to-use technologies that can be implemented in low and middle-income countries, where current methods are often impractical. By optimizing the ablation process, the study seeks to provide accessible treatment options that do not rely on complex equipment or continuous power supply. The approach includes point-of-care screening and diagnosis, ensuring that women in underserved regions can receive timely and effective care.
Who could benefit from this research
Good fit: Ideal candidates for this research are women living in low and middle-income countries who are at risk for cervical cancer.
Not a fit: Patients living in high-income countries with access to advanced cervical cancer treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce cervical cancer mortality rates among women in low and middle-income countries.
How similar studies have performed: Other research has shown promise in developing low-cost cervical cancer treatments, indicating that this approach could be effective.
Where this research is happening
Durham, United States
- Calla Health Foundation — Durham, United States (Active)
Researchers
- Principal investigator: Crouch, Brian — Calla Health Foundation
- Study coordinator: Crouch, Brian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.